Viking Therapeutics Completes Enrollment for Phase 3 VANQUISH-2 Study of VK2735 for Obesity Treatment Viking Therapeutics has completed patient enrollment in the Phase 3 VANQUISH-2 trial, aimed at evaluating VK2735 for obesity and type 2 diabetes. The study includes approximately 1,000 participants and will assess the drug's efficacy over 78 weeks.

Viking Therapeutics Completes Enrollment for Phase 3 VANQUISH-2 Study of VK2735 for Obesity Treatment #United_States #San_Diego #Clinical_Trial #Viking_Therapeutics #VK2735

Groundbreaking Clinical Trial Shows CathWorks FFRangio Matches Traditional PCI Outcomes A recent clinical trial at CRT 2026 revealed that CathWorks FFRangio technology led to outcomes comparable to invasive PCI methods in over 4,000 patients.

Groundbreaking Clinical Trial Shows CathWorks FFRangio Matches Traditional PCI Outcomes #USA #Washington #Clinical_Trial #CathWorks #FFRangio

Mimio Health's Innovative Fasting Mimetic Shows Positive Clinical Results Without Diet Changes Mimio Health unveils a groundbreaking study revealing its fasting mimetic product provides significant health benefits without dietary changes. Learn more!

Mimio Health's Innovative Fasting Mimetic Shows Positive Clinical Results Without Diet Changes #United_States #San_Francisco #Clinical_Trial #Fasting_Mimetic #Mimio_Health

NOVOS Core Clinical Trial Demonstrates Cardiovascular Advantages for Aging Adults A recent NOVOS clinical trial showcases significant cardiovascular benefits in older adults. This breakthrough could redefine healthy aging interventions and vascular health strategies.

NOVOS Core Clinical Trial Demonstrates Cardiovascular Advantages for Aging Adults #USA #New_York #Clinical_Trial #Longevity #NOVOS

Grünenthal's NaV 1.8 Inhibitor Advances to Clinical Trials Aiming for Non-Opioid Pain Relief Grünenthal has commenced a Phase I trial for its NaV 1.8 inhibitor, a promising non-opioid therapy for acute and chronic pain. Initial results are anticipated in late 2026.

Grünenthal's NaV 1.8 Inhibitor Advances to Clinical Trials Aiming for Non-Opioid Pain Relief #Germany #Clinical_Trial #Grünenthal #Aachen #NaV_1.8

Gyala Therapeutics Launches Phase I/IIa Clinical Trial for CAR-T Cell Therapy in Acute Leukemias Gyala Therapeutics has initiated a Phase I/IIa clinical trial to evaluate GYA01, a CAR-T cell therapy targeting acute leukemias with limited treatment options.

Gyala Therapeutics Launches Phase I/IIa Clinical Trial for CAR-T Cell Therapy in Acute Leukemias #Spain #Clinical_Trial #CAR-T_therapy #Valencia #Gyala_Therapeutics

NHS to trial potentially life-saving treatment for deadly liver disease Acute-on-chronic liver failure will be treated with device that cleans patients’ blood corrupted by toxins

Major breakthrough #clinical_trial for deadly #liver_disease. #NHS
www.theguardian.com/society/2025...

Anixa Biosciences Reveals Promising Phase 1 Results for New Breast Cancer Vaccine The latest findings from Anixa Biosciences highlight significant progress in the development of a breast cancer vaccine with favorable immune responses.

Anixa Biosciences Reveals Promising Phase 1 Results for New Breast Cancer Vaccine #USA #Anixa_Biosciences #San_Jose #Clinical_Trial #Breast_Cancer_Vaccine

Advarra Enhances Study Collaboration with New Clinical Trial Technology Integrations to Streamline Workflows Advarra announced new partnerships with top clinical trial technology providers, enhancing their Study Collaboration solution for streamlined access across platforms.

Advarra Enhances Study Collaboration with New Clinical Trial Technology Integrations to Streamline Workflows #USA #Columbia #Clinical_Trial #Advarra #Study_Collaboration

Regenerative Patch Technologies Marks Phase IIb Trial Progress for Macular Degeneration Treatment Regenerative Patch Technologies has treated its first two patients in a Phase IIb clinical trial aimed at improving vision for advanced dry age-related macular degeneration. This trial follows promising Phase I results.

Regenerative Patch Technologies Marks Phase IIb Trial Progress for Macular Degeneration Treatment #USA #Clinical_Trial #Menlo_Park,_California #Regenerative_Patch #RPE_Cell_Implant

First Patient Enrolled in Phase 2 Trial for Innovative Therapy in Late-Stage Pancreatic Cancer Amorphical has enrolled the first patient for its Phase 2 clinical trial evaluating a novel therapy aimed at mitigating stage IV pancreatic cancer, aiming to improve patient survival rates.

First Patient Enrolled in Phase 2 Trial for Innovative Therapy in Late-Stage Pancreatic Cancer #Israel #Clinical_Trial #pancreatic_cancer #Amorphical #Nes_Ziona

Suvoda Unveils Innovative Unified Patient App to Improve Clinical Trial Participation Suvoda has launched a groundbreaking application designed to streamline the clinical trial participation experience, alleviating logistical challenges for patients.

Suvoda Unveils Innovative Unified Patient App to Improve Clinical Trial Participation #USA #Clinical_Trial #Conshohocken #Suvoda #patient_app

Sequence LifeScience Launches Innovative Clinical Trial for Diabetic Foot Ulcers Sequence LifeScience has begun a pioneering clinical trial assessing diabetic foot ulcers utilizing placental membrane grafts, showcasing innovative treatment approaches.

Sequence LifeScience Launches Innovative Clinical Trial for Diabetic Foot Ulcers #USA #San_Antonio #Clinical_Trial #Diabetic_Foot_Ulcers #Sequence_LifeScience

Anixa Biosciences' Revolutionary Breast Cancer Vaccine Results to Be Revealed at 2025 San Antonio Symposium Anixa Biosciences is set to unveil the final outcomes of its pioneering breast cancer vaccine trial at the upcoming San Antonio Breast Cancer Symposium in 2025. This groundbreaking research has significant implications for treatment advancements.

Anixa Biosciences' Revolutionary Breast Cancer Vaccine Results to Be Revealed at 2025 San Antonio Symposium #United_States #Anixa_Biosciences #Breast_Cancer #Clinical_Trial #San_Jose,_California

TYBR Health Begins Clinical Trial of Innovative B3 GEL™ in Australia for Tendon Surgery TYBR Health has initiated its clinical trial for the B3 GEL™, focusing on improving post-surgical outcomes in tendon surgeries. This study signifies a major step towards enhancing patient recovery.

TYBR Health Begins Clinical Trial of Innovative B3 GEL™ in Australia for Tendon Surgery #Australia #Gold_Coast #Clinical_Trial #TYBR_Health #B3_GEL™

Veeva Partners with Amgen to Boost Clinical Trial Innovations Veeva Systems announces a significant partnership with Amgen aimed at enhancing clinical trial processes, accelerating drug development for serious diseases.

Veeva Partners with Amgen to Boost Clinical Trial Innovations #USA #Veeva_Systems #Barcelona #Clinical_Trial #Amgen

Revolutionizing Wound Care: MolecuLight's Imaging Technology Improves Healing Outcomes and Reduces Costs MolecuLight's innovative imaging technology is proving to enhance wound treatment significantly, offering faster healing and cost savings according to a groundbreaking clinical trial.

Revolutionizing Wound Care: MolecuLight's Imaging Technology Improves Healing Outcomes and Reduces Costs #Canada #Toronto #Clinical_Trial #Wound_Care #MolecuLight

IQVIA and Veeva Forge Robust Global Partnerships to Advance Clinical and Commercial Solutions IQVIA and Veeva Systems unveil new global partnerships aimed at advancing clinical trial processes and enhancing commercial operations, benefitting joint customers.

IQVIA and Veeva Forge Robust Global Partnerships to Advance Clinical and Commercial Solutions #USA #Clinical_Trial #Research_Triangle_Park #Veeva #IQVIA

BioLab Holdings, Inc. Initiates Pioneering Clinical Trial for Wound Care Solutions BioLab Holdings, Inc. has launched its most comprehensive clinical study to test human placental membrane products, aiming to enhance chronic wound care.

BioLab Holdings, Inc. Initiates Pioneering Clinical Trial for Wound Care Solutions #USA #Phoenix #Clinical_Trial #BioLab_Holdings #Human_Placental_Membrane

Rivus Pharmaceuticals Reports Success in Reducing Liver Fat with Phase 2 HU6 Trial for MASH Patients Rivus Pharmaceuticals' Phase 2 M-ACCEL trial of HU6 shows significant liver fat reduction in MASH patients, highlighting a promising treatment option.

Rivus Pharmaceuticals Reports Success in Reducing Liver Fat with Phase 2 HU6 Trial for MASH Patients #Clinical_Trial #MASH #Charlottesville #Rivus_HU6

PleoPharma, Inc. Unveils Promising Results in Cannabis Withdrawal Study at Major Conference PleoPharma, Inc. shared positive findings from their cannabis withdrawal syndrome clinical trial, highlighting the potential for their investigational drug to aid those with cannabis use disorder.

PleoPharma, Inc. Unveils Promising Results in Cannabis Withdrawal Study at Major Conference #United_States #New_Orleans #Clinical_Trial #PleoPharma #Cannabis_Use_Disorder

Bambusa Therapeutics Begins Phase 1 Trial for Innovative Bispecific Antibody BBT002 Bambusa Therapeutics has initiated a Phase 1 clinical trial for BBT002, a groundbreaking bispecific antibody targeting various inflammatory conditions, demonstrating impressive preclinical results.

Bambusa Therapeutics Begins Phase 1 Trial for Innovative Bispecific Antibody BBT002 #United_States #Boston #Clinical_Trial #Bambusa_Therapeutics #BBT002

Groundbreaking Results from Stand Up To Cancer's Immunotherapy Clinical Trial Challenge Conventional Cancer Treatments A recent clinical trial led by Memorial Sloan Kettering Cancer Center shows that immunotherapy may replace traditional cancer treatments for solid tumors, offering hope to patients worldwide.

Groundbreaking Results from Stand Up To Cancer's Immunotherapy Clinical Trial Challenge Conventional Cancer Treatments #United_States #Los_Angeles #Immunotherapy #Clinical_Trial #Stand_Up_To_Cancer

#clinical_trial
#angel

Promising Findings from ArtemiCafe's Cancer Trials Spark Hope for Ovarian Cancer Patients The ArtemiCafe® coffee trials yield positive results for ovarian cancer treatment, aiming for safer maintenance therapies post-chemotherapy.

Promising Findings from ArtemiCafe's Cancer Trials Spark Hope for Ovarian Cancer Patients #USA #cancer_therapy #Clinical_Trial #Camp_Hill #ArtemiCafe

Dermata's XYNGARI™ Clinical Trial Achieves Major Milestone in Acne Treatment Dermata Therapeutics announces groundbreaking results from its Phase 3 trial of XYNGARI™, a once-weekly treatment for moderate-to-severe acne, meeting all primary endpoints.

Dermata's XYNGARI™ Clinical Trial Achieves Major Milestone in Acne Treatment #United_States #San_Diego #Clinical_Trial #Dermata_Therapeutics #XYNGARI

Bantam Pharmaceutical Advances BTM-3566 Trial With Expansion into Canada Bantam Pharmaceutical is advancing its Phase 1 clinical trial for BTM-3566 by expanding into Canada, targeting aggressive B-cell lymphomas.

Bantam Pharmaceutical Advances BTM-3566 Trial With Expansion into Canada #Canada #Clinical_Trial #Research_Triangle_Park #Bantam_Pharmaceutical #BTM-3566

LyGenesis Secures Approval to Advance Phase 2a Clinical Trial for Liver Regeneration LyGenesis, Inc. has received the go-ahead for its Phase 2a clinical trial from the Data and Safety Monitoring Board, marking a significant milestone for organ regeneration research.

LyGenesis Secures Approval to Advance Phase 2a Clinical Trial for Liver Regeneration #United_States #Pittsburgh #Clinical_Trial #LyGenesis #organ_regeneration

Movano Health Launches Groundbreaking Clinical Study for Cuffless Blood Pressure Monitoring Device Movano Health has initiated a clinical trial for its innovative cuffless blood pressure device, aiming to transform health monitoring.

Movano Health Launches Groundbreaking Clinical Study for Cuffless Blood Pressure Monitoring Device #United_States #Clinical_Trial #Pleasanton #Movano_Health #Cuffless_Device

Q2i's Innovative PARCA Technology Advances to Phase II for Justice-Involved Support Q2i's Probation and Reentry Coach Application (PARCA) transitions to Phase II following a successful NIH Phase I trial, aiming to enhance community supervision.

Q2i's Innovative PARCA Technology Advances to Phase II for Justice-Involved Support #United_States #Boston #Clinical_Trial #Q2i #PARCA